Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032

Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032

The global glycomics/glycobiology market size is expected treach USD 5.24 billion by 2032, according ta new study by Polaris Market Research. The report “Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

Rising investments and implementation on glycomics research by both government and private organizations, high development of many novel drugs & therapeutics, and progress in proteomics are key factors boosting global market growth.

In the last decades, glycomics has gained high popularity as an emerging field of research and has a wide range of applications in oncology, diagnostics, drug discovery, and immunology and is alsbeing used in determining cancer cells and regulating cell regulation. Thus, the market is expected tgrow significantly and have huge opportunities shortly. For instance, in April 2022, Bruker announced the availability of its new novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex combined with unbiased lipidomics, metabolomics, and glycomics tissue imaging.

The growing prevalence of cancer and other related diseases among people worldwide has led tthe rising use of glycobiology in research activities for cancer treatment, because of the relevance of surface glycan in both neoplastic and metastatic characteristics of tumor cells present in human body. Lung cancer amounted ta leading number of cancer deaths, with a total estimated 1.8 million deaths followed by colorectal with about 1 million deaths.

Furthermore, precision medicine has rapidly grown in recent years and many large pharma and biotech companies are investing larger funds tdevelop various targeted drugs, which can be effectively used for a specific patient group. In addition, a researcher has alsshown that the mutation in glycosyltransferases or other related enzymes alters the glycome and alscauses over 100 types of human congenital disorders.

Glycomics/Glycobiology Market Report Highlights

Instruments segment accounted for largest market share in 2022 on account of increasing adoption of innovative instruments across various applications including diagnostics

Drug discovery & development segment held the largest market revenue share in 2022, owing tthe increase in prevalence of personalized medicine taddress chronic diseases

Pharmaceutical & biotechnology companies are likely tbe the largest end-use segment over the forecast period due tthe increased investment and efforts by the companies on technology development and product enhancement.

North America dominated the global market in 2022, which is highly attributed tthe growing proliferation of precision medicine and increasing healthcare spending in countries like the US and Canada.

The global key market players include ThermFisher Scientific, Agilent Technology, New England Biolabs, SumitomBakelite, and Danaher Corporation

Polaris Market Research has segmented the glycomics/glycobiology market report based on product, application, end-use, and region:

Glycomics/Glycobiology, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Enzymes

Kits

Reagents

Instruments

Glycomics/Glycobiology, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Drug Discovery & Development

Diagnostics

Others

Glycomics/Glycobiology, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

Academic & Research Institute

Pharmaceutical & Biotechnology Companies

CROs

Glycomics/Glycobiology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa